ATP-CITRATE LYASE AS A TARGET FOR HYPOLIPIDEMIC INTERVENTION - SULFOXIMINE AND 3-HYDROXY-BETA-LACTAM CONTAINING ANALOGS OF CITRIC-ACID AS POTENTIAL TIGHT-BINDING INHIBITORS
ATP-CITRATE LYASE AS A TARGET FOR HYPOLIPIDEMIC INTERVENTION - SULFOXIMINE AND 3-HYDROXY-BETA-LACTAM CONTAINING ANALOGS OF CITRIC-ACID AS POTENTIAL TIGHT-BINDING INHIBITORS
复制标题
DOI:
10.1021/jm00104a014
复制
发表时间:
1992-12-25
影响因子:
7.3
通讯作者:
GROOT, PHE
中科院分区:
文献类型:
--
作者:
DOLLE, RE;MCNAIR, D;GROOT, PHE
Citric acid analogues (+/-)-12a,b and (+/-)-17a,b, where one of the primary carboxylates has been replaced by a sulfoximinoyl and a 3-(3-hydroxy-beta-lactamyl) moiety, respectively, have been synthesized and evaluated as inhibitors of ATP-citrate lyase. The design of these inhibitors was based on methionine sulfoximine and tabtoxinine beta-lactam, potent, tight-binding inhibitors of glutamine synthetase. Both ATP-citrate lyase and glutamine synthetase employ phosphate-carboxylate anhydrides as a method for carboxylate activation during catalysis. Only one diastereomer, (+/-)-12a, displayed weak, reversible inhibition, while the remaining citrate analogues (+/-)-12b and (+/-)-17a,b were inactive against the lyase. No time-dependent inactivation of the enzyme was observed.